Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis

Leukemia and Lymphoma

Volumn 30, Issue 3-4, 1998, Pages 257-267

  Chapman, Caroline J ^a   Wright, Dennis ^a   Stevenson, Freda K ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Burkitt's lymphoma; Immunoglobulin V(H) and V(L) genes

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SUBSTITUTION; B LYMPHOCYTE; BURKITT LYMPHOMA; COMPLEMENTARITY DETERMINING REGION; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; MUTATION RATE; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TUMOR BIOPSY; TUMOR CELL LINE;

EID: 0031815647     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057539     Document Type: Review

References (68)

1. Wright, D. H. (1997). What is Burkitt's Lymphoma? J. Pathology, 182, 125-127.
2. Burkitt, D. P. (1958). Sarcoma involving jaws in African children. Br. J. Surg., 46, 218-223.
3. Wright. D. H. (1963). Involvement of the jaw in Burkitt's tumor. Lancet, 2, 151.
4. Burkitt, D. P. (1967). Burkitt's lymphoma outside the known endemic areas of Africa and New Guinea. Int. J. Cancer, 2, 562-565.
5. Berard, C., O'Conor, G. T., Thomas, L. B. and Torloni, H. (1969). Histopathological definition of Burkitt's tumor. Bull. WHO, 40, 601-607.
6. Wright, D., Maclver, P. and Carter, R. (1997). Childhood non-Hodgkin's lymphomas in the United Kingdom: findings from the UK children's cancer study group. J. Clin. Path., 50, 128-134.
7. Magrath, I. (1990). The Pathogenesis of Burkitt's Lymphoma. Adv. Cancer. Res., 55, 133-270.
8. Lenoir, G., Philip, T. and Sohier, R. (1984). Burkitt type lymphoma: EBV association and cytogenetic markers in cases from various geographical locations. In Pathogenesis of Leukaemias and Lymphomas: Enviromnental Influences, I.T. Magrath, G.T. O'Conor and B. Ramat (eds.), pp. 285-296. (Raven Press, New York).
9. Rowe, M., Rooney, C. M., Edwards, C. E., Lenoir, G. M. and Rickinson, A. B. (1986). Epstein-Barr virus status and tumor cell phenotype in sporadic Burkitt's lymphoma. Int. J. Cancer, 37, 367-373.
10. Burkitt, D. P. (1970). General features and facial tumors. In Burkitt's Lymphoma, D.P. Burkitt and D.H. Wright (eds.), pp6-15. (E and S Livingstone, Edinburgh and London).
11. Wright, D. H. (1970). Gross distribution and morphology. In Burkitt's Lymphoma, D.P. Burkitt, and D.H. Wrights, (eds.), pp. 64-81, (E and S Livingstone, Edinburgh and London).
12. Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. W. and Croce, C. M. (1982). Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA, 79, 7824-7827.
13. Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S. and Leder, P. (1982). Translocation of the e-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA, 79, 7837-7841.
14. Cesarman, E., Dalla-Favera, R., Bentley, D. and Groudine, M. (1987). Mutations in the first exon are associated with altered transcription of c-myc in Burkitt's lymphoma. Science, 238, 1272-1275.
15. Rabbitts, T. H., Hamlyn, P. H. and Baer, R. (1983). Altered nucleotide sequences of a traslocated c-myc gene in Burkitt's lymphoma. Nature, 306, 760-765.
16. Bhatia, K., Huppi, K., Sangler, G., Siwarski, D., Iyer, R. and Magrath, I. (1993). Point mutations in the c-myc transactivalion domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nature Genetics, 5, 56-61.
17. Guy, K., Middleton, P. G., Bonsal, N. S., Ross, J. A. and Stell, C. M. (1999). Recurrent mutation of immunoglobulin and c-myc genes and differentiated expression of cell surface antigens occur in varient cell lines derived from a Burkitt's lymphoma. Int. J. Cancer, 45, 109-118.
18. Zeigler, J. L., Beckstead, J. A., Volberding, P. A., Abrams, D. I., Levine, A. M., Likes, R. J., Gill, P. S., Burkes, R. L., Meyer, P. R., Metroka, C. E., Mouradian, J., Moore, A., Riggs, S. A., Butler, J. J., Cabanillas, F. C., Hersh, E., Newell, G. R., Laubenstein, L. J., Knowles, D., Odajnyk, C., Raphael, B., Koziner, B., Urmacher, C. and Clarkson, B. D. (1984). Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalised lymphadenopathy and the acquired immunodeficiency syndrome. N. Engl. J. Med., 311, 565-570.
19. Pillici, P., Knowles, D., Magrath, I. and Dalla-Favera, R. (1986). Chromosomal breakpoints and the structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA, 83, 2984-2990.
20. Subar, M., Neri, A., Inghirami, G., Knowles, D. M. and Dalla-Favera, R. (1988). Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood, 72, 667-671.
21. Hamilton-Dutoit, S. J., Raphael, M., Audouin, J., Diebold., J., Lisse, I., Pedersen, C., Oksenhendler, E., Marelle, I. and Pallensen, G. (1993). In situ demonstration of Epstein-Barr virus small RNAs (EBER-1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood, 92, 610-624.
22. Mann, R. B., Jaffe, E. S., Braylan, R. C., Nanba, K., Frank, M. M., Zeigler, J. L. and Berard, C. W. (1976). Non-endemic Burkitt's lymphoma: a B-cell tumor related to germinal centers. N. Engl. J. Med., 295, 685-691.
23. Wright, D. H. (1985). Histogenesis of Burkitt's lymphoma. In Burkitt's Lymphoma: A Human Cancer Model, G. Lenoir, G. O'Conor and C.L.M. Olweny (eds.), pp37-45, (IARC Scientific Publications, Lyon).
24. Bahler, D. W., Cambell, M. J., Hart, S., Miller, R. A., Levy, S. and Levy. R. (1991). Ig VH gene expression among human follicular lymphomas. Blood, 78, 1561-1568.
25. Stevenson, F. K., Spellerberg, M. B., Treasure, J., Chapman, C. J., Silberstein, L. E., Hamblin, T. J. and Jones, D. B. (1993). Differential usage of an Ig heavy chain variable region gene by human B-cell tumors. Blood, 82, 224-230.
26. Hsu, F. J. and Levy, R. (1997). Preferential use of the VH4 Immunoglobulin gene family by diffuse large cell lymphoma. Blood, 86, 3072-3082.
27. Johnson, T. A., Razzenti, L. Z. and Kipps, T. J. (1997). Ig VH1 genes expressed in B-cell chronic lymphocytic leukemia exhibit distinctive molecular features. J. Immunol., 158, 235-246.
28. Oseier, D. G., Thompsett, A., Zhu, D. and Stevenson, F. K. (1997). Differential rates of somatic hypermutation in VH genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood, 89, 4153-4160.
29. Stevenson, F. K., Spellerberg, M. B., Chapman, C. J. and Hamblin, T. J. (1995). Differential usage of an autoantibody-associated VH gene, VH4-21, by human B-cell tumors. Leuk. Lymphoma, 16, 379-384.
30. + B-cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood, 82, 3103-3112.
31. Bessudo, A., Cherepakhin, V., Johnson, T. A., Razzenti, L. Z., Feigal, E. and Kipps, T. J. (1996). Favored use of immunoglobulin VH4 genes in AIDS-associated B-cell lymphoma. Blood, 88, 252-260.
32. Berek, C. and Milstein, C. (1987). Mutation drift and repertoire shift in the maturation of the immune response. Immunol. Rev., 96, 23-41.
33. Kocks, C. and Rajewsky, K. (1989). Stable expression and somatic hypermutation of antibody V regions in B-cell development pathways. Ann. Rev. Immunol., 7, 537-559.
34. Hummel, M., Tamaru, J., Kalvelage, B. and Stein, H. (1994). Mantle Cell (Previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood, 84, 403-407.
35. Kuppers, R., Rajewsky, K. and Hansmann, M.-L. (1997). Diffuse large cell lymphomas are derived from mature B-cells carrying V region genes with a high load of somatic mutations and evidence of selection for antibody expression. Eur. J. Immunol., 27, 1398-1405.
36. Sahota, S., Hamblin, T., Oseier, D. G. and Stevenson, F. K. (1994). Assessment of the role of clonogenic B-lymphocytes in the pathogenesis of multiple myeloma. Leukemia, 8, 1285-1289.
37. Qin, Y., Greiner, A., Trunk, M. J. K., Schmausser, B., Ott, M. M. and Muller-Herelink, H. K. (1995). Somatic hypermutation in low-grade mucose-associated lymphoid tissue-type B-cell lymphoma. Blood, 86, 3528-3534.
38. Zelenetz, A. D., Chen, T. T. and Levy, R. (1992). Clonal expansion in follicular lymphoma occurs subsequent to antigenie selection. J. Exp. Med., 176, 1137-1148.
39. Bahler, D. W. and Levy, R. (1992). Clonal evolution of a follicular lymphoma: Evidence for antigen selection. Proc. Natl. Acad. Sci. USA, 89, 6770-6774.
40. Zhu, D., Hawkins, R. E., Hamblin, T. J. and Stevenson, F. K. (1994). Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes. Br. J. Haem., 86, 505-512.
41. Bahler, D. W., Miklos, J. A. and Swerdlow, S. H. (1997). Ongoing Ig hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood, 89, 3335-3344.
42. Moazzeni, M., Mosayyebi, G., Stevenson, F. K., Abbot, S., Mageed, R. A. and Shokri, F. (1994). Biased utilization of immunoglobulin variable region heavy and light chain genes by the malignant CD5-negative B lymphocytes from patients with Burkitt's lymphoma. Int. J. Cancer, 58, 226-232.
43. Chapman, C. J., Mockridge, C. I., Rowe, M., Rickinson, A. and Stevenson, F. K. (1995). Analysis of VH genes used by neoplastic B-cells in endemic Burkitt's lymphoma show somatic hypermutation and intraclonal heterogeneity. Blood, 85, 2176-2181.
44. Chapman, C. J., Zhou, J. X., Gregory, C., Rickinson, A. and Stevenson, F. K. (1996). VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood, 88, 3562-3568.
45. Klein, U., Klein, G., Ehlin-Henriksson, B., Rajewsky, K. and Küppers, R. (1995). Burkitt's Lymphoma is a malignancy of mature B-cells expressing somatically mutated V region genes. Mol. Med., 1, 495-505.
46. Cowley, C. G., Carroll, W. L. and Johnston, J. M. (1996). The absence of ongoing immunoglobulin gene hypermutation suggests a distinct mechanism for c-myc mutation in endemic Burkitt's lymphoma. J. Ped. Hamatol./Oncol., 18, 29-35.
47. Tamaru, J., Hummel, M., Marafioti, T., Kavelage, B., Leoncini, L., Minacci, C., Tosi, P., Wright, D. and Stein, H. (1995). Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am. J. Pathol., 147, 1398-1407.
48. H4-21 segments. Blood, 83, 2952-2960.
49. H-gene putative somatic mutation analysis. Blood, 83, 1067-1078.
50. Jain, R., Roncella, S., Hashimoto, S., Carbone, A., Francia de Celle, P., Foa, R., Ferrarini, M. and Chiorazzi, N. (1994). A potential role for antigen selection in the cional evolution of Burkitt's Lymphoma. J. Immunol., 153, 45-52.
51. Echlache, V., Magnac, C., Pritsch, O., Delecluse, H.-J., Davi, F., Raphael, M. and Dighiero. G. (1996). Complete nucleotide sequence of Ig V genes in cases of Burkitt lymphoma associated with AIDS. Leuk. Lymphoma, 20, 281-290.
52. Daley, M. D., Berinstein, N. L. and Siminovitch, K. A. (1994). Immunoglobulin heavy chain variable gene utilization in human large cell and Burkitt's lymphoma cell lines. Clin. Invest. Med., 17, 522-530.
53. Carroll, W. L., Yu, M., Link, M. P. and Korsmeyer, S. J. (1989). Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma. J. Immunol., 143, 692-698.
54. + and CD5-/IgM+ B cells. J. clin. Invest., 99, 2488-2501.
55. Cook, G. P., Tomlinson, I. H., Walter, G., Riethman, H., Carter, N. P., Buluwela, L., Rabbitts, T. H. and Winter, G. (1994). A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat. Genet., 7, 162-168.
56. Stevenson, F. K., Smith, G. J. North, J., Hamblin, T. J. and Glennie, M. J. (1989). Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anit-1 and anti-i specificity. Br. J. Haematol., 72, 9-15.
57. Kraj, P., Friedman, D. F., Stevenson, F. and Silberstein, L. E. (1995). Evidence for the overexpression of the V4-34 (VH4.21) Ig gene segment in the normal adult human peripheral blood B cell repertoire. J. Immunol., 154, 6406-6420.
58. Shutte, M. E. M., van Es, J. H., Silberstein, L. E. and Logtenberg, T. (1993). VH4-21-encoded natural autoantibodies with anti-i specificty mirror those associated with cold hemagglutinin disease. J. Immunol., 151, 6569-6576.
59. H genes are inherently susceptible to animo acid replacement. Immunol. Today, 15, 367-373.
60. Gutterez, M., Bhatia, K., Barriga, F., Diez, B., Muriel, F. S., de Andreas, M. L., Epelman, S., Risveno, C. and Magrath, I. T. (1992). Molecular epidemiology of Burkitt's lymphoma from South America: Differences in breakpoint location and Epstein-Barr virus association from tumours in other world regions. Blood, 79, 3261-3266.
61. Neri, A., Barega, F., Knowles, D., Magrath, I. and Dalla-Favera, R. (1988). Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenic forms of Burkitt's lymphoma. Proc. Nat. Acad. Sci. USA, 85, 2748-2754.
62. Chapman, C. J., Spellerberg, M. B.. Smith, G. A., Carter, N. P., Hamblin, T. J. and Stevenson, F. K. (1993). Autoantired cell antibodies synthesized by patients with infectious mononucleosis utilize VH4-21 gene segment. J. Immunol., 151, 1051-1061.
63. Berberian, L., Valles-Ayoub, Y., Sun, N., Martinez-Maza, O. and Braun, J. (1991). A VH clonal deficit in human immuno-deficiency virus positive individuals reflects a B-cell maturation arrest. Blood, 78, 175-179.
64. David, D., Demaison, C., Bani, L., Zouali, M. and Theze, J. (1995). Selective variations in vivo of VH3 and VH1 gene family expression in peripheral B-cell IgM, IgD and IgG during HIV infection. Eur. J. Immunol., 25, 1524-1528.
65. Rassenti, L. Z., Kohsaka, H. and Kipps, T. J. (1995). Analysis of immunoglobulin VH gene repertoire by an anchored PCR-ELISA. Ann. N.Y. Acad. Sci., 764, 463-473.
66. Przybylski, G. K., Goldman, J., Ng, V. L., McGrath, M. S., Herndier, B. G. Schenken, D. P., Monroc, J. G. and Silberstein, L. E. (1996). Evidence for early B-cell activation preceding the development of Epstein-Barr Virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood, 88, 4620-4629.
67. Stamatopoulos, K., Kosmas, C., Papadaki, T., Pouliou, E., Belessi, C., Afendaki, S., Anagnostou, D. and Loukopoulos, D. (1997). Follicular lymphoma immunoglobulin k light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains. Br. J. Haematol., 96, 132-146.
68. Denepoux, S., Razánajaona, D., Blanchard, D., Meffre, G., Capra, J. D., Banchereau, J. and Lebecque, S. (1997). Induction of somatic mutation in a human B cell line in vitro. Immunity, 6, 35-46.